HB 127: Pharmaceuticals; prohibiting the Board of Pharmacy from disciplining pharmacists who recommend off-label use of a drug; allowing over-the-counter sale of Ivermectin and Hydroxychloroquine.
Latest action, Jan. 13, 2026: Pending House Health
The bill’s record: its number and title, where it stands, its sponsors, every action in its legislature’s words, every version, the roll calls on it, and every change the site recorded, with LegiScan’s license.